Suzhou fujilai Pharmaceutical Co., Ltd
Initial public offering and listing on GEM
Announcement of issuance results
Sponsor (co lead underwriter): Orient Securities Company Limited(600958) underwriting sponsor Co., Ltd
Co lead underwriter: Guotai Junan Securities Co.Ltd(601211)
hot tip
The application of Suzhou fujilai Pharmaceutical Co., Ltd. (hereinafter referred to as “fujilai”, “issuer” or “company”) for initial public offering of no more than 22.92 million ordinary shares (A shares) and listing on the gem (hereinafter referred to as “this offering”) has been examined and approved by the GEM Listing Committee of Shenzhen Stock Exchange (hereinafter referred to as “Shenzhen Stock Exchange”), It has been registered by China Securities Regulatory Commission (hereinafter referred to as “CSRC”) (zjxk [2022] No. 251). The sponsor (co lead underwriter) of this offering is Orient Securities Company Limited(600958) underwriting sponsor Co., Ltd. (hereinafter referred to as “sponsor (co lead underwriter)” or “Oriental Investment Bank“) The lead underwriter of the investment bank (hereinafter referred to as the “lead underwriter”) and the joint underwriter of the investment bank (hereinafter referred to as the “joint underwriter”). The issuer’s stock is abbreviated as “fujilai” and the stock code is “301258”.
This issuance is finally carried out by a combination of offline inquiry and placement to qualified investors (hereinafter referred to as “offline issuance”) and online pricing issuance to social public investors holding non restricted A-share shares and non restricted depositary receipts in Shenzhen market (hereinafter referred to as “online issuance”).
The issuer and the joint lead underwriters negotiated and determined that the number of shares issued this time is 22.92 million shares. The issue price is 48.30 yuan / share. The issuing price of this offering shall not exceed the median and weighted average of the quotations of offline investors after excluding the highest quotation, as well as the Securities Investment Fund (hereinafter referred to as “public fund”), the National Social Security Fund (hereinafter referred to as “social security fund”), the basic old-age insurance fund (hereinafter referred to as “pension”) established through public offering after excluding the highest quotation The enterprise annuity fund (hereinafter referred to as “enterprise annuity fund”) established in accordance with the measures for the administration of enterprise annuity fund and the insurance fund (hereinafter referred to as “insurance fund”) in accordance with the measures for the administration of the use of insurance funds, whichever is lower. According to the issuing price, the relevant subsidiaries of the sponsor will not participate in the strategic placement. The maximum amount of 1146000 shares was transferred back to offline issuance.
After the strategic placement call back and before the online and offline call back mechanism was launched, the initial number of offline shares was 16.388 million, accounting for 71.50% of the number of shares issued this time; The initial number of shares issued online was 6.532 million, accounting for 28.50% of the number issued this time. According to the callback mechanism announced in the announcement of Suzhou fujilai Pharmaceutical Co., Ltd. on initial public offering and listing on the gem (hereinafter referred to as the “issuance announcement”), the issuer and the joint lead underwriters decided to start the callback mechanism because the initial effective subscription multiple on the Internet was 1027655090 times, higher than 100 times, 20% (rounded up to an integral multiple of 500 shares, i.e. 4584000 shares) of the number of shares issued this time will be transferred back from offline to online. After the call back, the final number of offline shares issued was 11.804 million, accounting for 51.50% of the total issued this time; The final number of shares issued online was 11.116 million, accounting for 48.50% of the total issued this time. After the callback mechanism was launched, the final winning rate of online issuance was 00165597961%. The online and offline subscription and payment work of this offering has been completed on March 21, 2022 (T + 2). The details are as follows:
1、 Statistics of new share subscription
According to the data provided by Shenzhen Stock Exchange and Shenzhen Branch of China Securities Depository and Clearing Corporation Limited (hereinafter referred to as “Shenzhen Branch of China Securities Depository and Clearing Corporation”), the joint lead underwriters have made statistics on the subscription of new shares issued online and offline. The results are as follows:
(I) online subscription of new shares
1. Number of shares subscribed by online investors (shares): 11038850
2. Subscription amount paid by online investors (yuan): 53317645500
3. Number of shares abandoned by online investors (shares): 77150
4. Amount of subscription abandoned by online investors (yuan): 372634500
(II) offline subscription of new shares
1. Number of shares subscribed by offline investors (shares): 11804000
2. Subscription amount paid by offline investors (yuan): 57013320000
3. Number of shares that offline investors give up subscription (shares): 0
4. Amount of subscription abandoned by offline investors (yuan): 0
2、 Offline proportional restriction
The offline issuance part adopts the proportional sales restriction method, and the offline investors shall promise that the sales restriction period of 10% (rounded up) of the number of shares allocated to them is 6 months from the date of the issuer’s initial public offering and listing. That is, among the shares allocated to each placing object, 90% of the shares are sold indefinitely and can be circulated from the date when the issued shares are listed and traded on the Shenzhen Stock Exchange; The sales restriction period of 10% of the shares is 6 months, and the sales restriction period starts from the date when the issued shares are listed and traded on the Shenzhen Stock Exchange.
When offline investors participate in the preliminary inquiry and quotation and offline purchase, they do not need to fill in the arrangement of the restricted sale period for the placing objects under their management. Once the quotation is made, it is deemed to accept the arrangement of the online restricted sale period disclosed in this announcement.
In this offering, the number of shares whose offline proportion is restricted for six months is 1184117, accounting for about 10.03% of the total offline issuance and 5.17% of the total public offering.
3、 Underwriting by the recommendation institution (joint lead underwriter)
The number of shares abandoned by online and offline investors is underwritten by the sponsor (joint lead underwriter). The number of shares underwritten by the sponsor (joint lead underwriter) is 77150 shares, and the underwriting amount is 372634500 yuan. The number of shares underwritten by the recommendation institution (joint lead underwriter) accounts for 0.34% of the total number of shares issued. On March 23, 2022 (T + 4), the recommendation institution (co lead underwriter) transferred the underwriting funds and the funds raised from offline and online issuance to the issuer after deducting the recommendation and underwriting fee. The issuer shall submit an application for share registration to CSDCC Shenzhen Branch and register the underwritten shares to the securities account designated by the sponsor (joint lead underwriter).
4、 Contact information of CO lead underwriters
If investors have any questions about the issuance results announced in this announcement, please contact the joint lead underwriters of this issuance.
The specific contact information is as follows:
Sponsor (co lead underwriter): Orient Securities Company Limited(600958) underwriting sponsor Co., Ltd
Address: floor 24, No. 318, Zhongshan South Road, Huangpu District, Shanghai
Tel.: 0212313864 contact person: CO lead underwriter of equity capital market department: Guotai Junan Securities Co.Ltd(601211) address: 37th floor, Bohua Plaza, No. 669, Xinzha Road, Jing’an District, Shanghai contact person: capital market department Tel.: 02138676888 Fax: 02168876330
Issuer: sponsor of Suzhou fujilai Pharmaceutical Co., Ltd. (co lead underwriter): Orient Securities Company Limited(600958) underwriting sponsor co lead underwriter: Guotai Junan Securities Co.Ltd(601211) March 23, 2022 (seal page of the announcement on the results of Suzhou fujilai Pharmaceutical Co., Ltd. initial public offering and listing on the GEM)
Suzhou fujilai Pharmaceutical Co., Ltd. (no text on this page, which is the seal page of the announcement on the results of Suzhou fujilai Pharmaceutical Co., Ltd. initial public offering and listing on the GEM)
Orient Securities Company Limited(600958) underwriting and recommendation Co., Ltd. (this page has no text and is the seal page of the announcement on the results of initial public offering and listing on the gem of Suzhou fujilai Pharmaceutical Co., Ltd.)
Guotai Junan Securities Co.Ltd(601211) mm / DD / yyyy
